GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Novadaq Technologies Inc (NAS:NVDQ) » Definitions » EPS without NRI

Novadaq Technologies (Novadaq Technologies) EPS without NRI : $-0.97 (TTM As of Jun. 2017)


View and export this data going back to 2012. Start your Free Trial

What is Novadaq Technologies EPS without NRI?

Novadaq Technologies's earnings per share without non-recurring items for the three months ended in Jun. 2017 was $-0.21. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2017 was $-0.97.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Novadaq Technologies's EPS without NRI or its related term are showing as below:

NVDQ's 3-Year EPS without NRI Growth Rate is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.25
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Novadaq Technologies's EPS (Diluted) for the three months ended in Jun. 2017 was $-0.21. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2017 was $-0.97.

Novadaq Technologies's EPS (Basic) for the three months ended in Jun. 2017 was $-0.21. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2017 was $-0.97.


Novadaq Technologies EPS without NRI Historical Data

The historical data trend for Novadaq Technologies's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novadaq Technologies EPS without NRI Chart

Novadaq Technologies Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.32 -0.47 -0.44 -0.63 -0.93

Novadaq Technologies Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.29 -0.19 -0.33 -0.24 -0.21

Competitive Comparison of Novadaq Technologies's EPS without NRI

For the Diagnostics & Research subindustry, Novadaq Technologies's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novadaq Technologies's PE Ratio without NRI Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Novadaq Technologies's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Novadaq Technologies's PE Ratio without NRI falls into.



Novadaq Technologies EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novadaq Technologies  (NAS:NVDQ) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Novadaq Technologies EPS without NRI Related Terms

Thank you for viewing the detailed overview of Novadaq Technologies's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Novadaq Technologies (Novadaq Technologies) Business Description

Traded in Other Exchanges
N/A
Address
Novadaq Technologies Inc was incorporated under the Canada Business Corporations Act on April 14, 2000. The Company develops and commercializes medical imaging and therapeutic devices for use in the operating room. It's imaging platform can be used to visualize blood vessels, nerves and the lymphatic system during surgical procedures. The Company's business activities are conducted through one segment, which consists of medical devices. Its product includes, SPY Elite, PINPOINT Endoscopic Fluorescence Imaging, FIREFLY System for Robotic Surgery, LUNA Fluorescence Angiography and CO2 HEART LASER System. The SPY Imaging System provides clinically relevant information that empowers surgeons to make informed critical decisions in the operating room. PINPOINT Endoscopic Fluorescence Imaging System combines all of the fluorescence imaging capabilities of SPY Imaging with the HD visible light imaging capabilities of a traditional endoscopic imaging system. FIREFLY system enables surgeons performing robotic surgery to benefit from fluorescence imaging, with initial use in applications ranging from urology to gynecology. LUNA fluorescence angiography enables clinicians to visually assess tissue perfusion in diabetic foot ulcers and non-healing wounds. The CO2 HEART LASER System consists of: the CO2 HEART LASER mobile console and the CO2 HEART LASER disposable hand pieces. The Company's intellectual property consists of 49 patent families representing 128 granted or allowed patents and 90 pending applications in various stages of review and prosecution.

Novadaq Technologies (Novadaq Technologies) Headlines

From GuruFocus

Baron Funds Comments on Novadaq Technologies

By Holly LaFon Holly LaFon 01-20-2017

Prem Watsa Increases Novadaq Technologies Ownership to 6.6 Pct

By Holly LaFon Holly LaFon 02-14-2013